Bain Capital, Mitsubishi Tanabe Pharma

Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's drug industry.
Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal
Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous system and metabolic disease.
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business for More Than $3 Billion
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key businesses.
Mitsubishi Chemical to sell drug unit to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it seeks to streamline its portfolio.
Bain Capital to buy Mitsubishi Chemical’s pharma unit for $3.3B
Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 billion USD).
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") in a carve-out transaction from Mitsubishi Chemical Group Corporation.
Mitsubishi books $342 million charge on Japan offshore wind projects
Japan's Mitsubishi Corp took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in ...
The Mitsubishi MU-2: A Look At Japan’s Most Successful Post-War Aircraft
Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...
Power Technology on MSN3d
Mitsubishi takes $342.4m impairment charge on domestic offshore wind
Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.
Mitsubishi reviews Japan offshore wind projects amid market shifts
Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...
Mitsubishi is speeding towards a financial cliff
Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.
Mitsubishi Reviews Japanese Offshore Wind After Economic Changes
Mitsubishi Corp. is reviewing business plans for three Japanese offshore wind power projects following macroeconomic changes, ...
Japan's Mitsubishi 9-month net profit up 19% y/y
Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...
Mitsubishi Corporation (MSBHF) Q3 2025 Earnings Call Transcript
Mitsubishi Corporation ( OTCPK:MSBHF) Q3 2025 Results Conference Call February 6, 2025 ET Katsuya Nakanishi - President, Chief Executive Officer Yuzo Nouchi - Executive Vice President, Chief Financial ...